Involvement of retinoblastoma protein in dibutyryl cyclic AMP-induced growth inhibition of the human hepatoma cells PLC/PRF/5

International Hepatology Communications

Volumn 5, Issue 6, 1996, Pages 331-338

  Okamoto, Yasuyuki ^a   Kikukawa, Masaji ^a   Nakano, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

antisense; DNA synthesis; human bladder tumor cells HT 1376; oligodeoxynucleotides

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BUCLADESINE; DNA; MESSENGER RNA; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0030271868     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-4346(96)00315-5     Document Type: Article

References (32)

1. [1] Cho-Chung YS, Clair T, Bodwin JS et al. Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine. Science 1981; 214: 77-79.
2. [2] Giuffre L, Schreyer M, Mach J-P et al. Cyclic AMP induces differentiation in vitro of human melanoma cells. Cancer 1988; 61: 1132-1141.
3. [3] Van Wijk R, Wicks WD, Clay K. Effects of derivatives of cyclic 3′,5′-adenosine monophosphate on the growth, morphology, and gene expression of hepatoma cells in culture. Cancer Res 1972; 32: 1905-1911.
4. [4] Van Wijk R, Wicks WD, Bevers MM et al. Rapid arrest of DNA synthesis by N6,O2′-dibutyryl cyclic adenosine 3′,5′-monophosphate in cultured hepatoma cells. Cancer Res 1973; 33: 1331-1338.
5. [5] Nose K, Katsuta H. Arrest of cultured rat liver cells in G2 phase by the treatment with dibutyryl cAMP. Biochem Biophys Res Commun 1975; 64: 983-988.
6. [6] Toni M, Miyake K, Kanai K. Effects of dibutyryl adenosine 3′-5′ cyclic monophosphate on thé ultrastructure of rat ascites hepatoma cells and on the intracellular localization of α-fetoprotein. Gann 1984; 75: 1083-1088.
7. [7] Tagliaferri P, Katsaros D, Clair T et al. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues. Cancer Res 1988; 48: 1642-1650.
8. [8] Wu J, Dent P, Jelinek T et al. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 1993; 262: 1065-1069.
9. [9] Cook SJ, McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science 1993; 262: 1069-1072.
10. [10] Frodin M, Peraldi P, Obberghen EV. Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem 1994; 269: 6207-6214.
11. [11] Ahn NG. The MAP kinase cascade. Discovery of a new signal transduction pathway. Mol Cell Biochem 1993; 127/128: 201-209.
12. [12] Farnham PJ, Slansky JE, Kollmar R. The role of E2F in the mammalian cell cycle. Biochim Biophys Acta 1993; 1155: 125-131.
13. [13] Mihara K, Cao X-R, Yen A et al. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 1989; 246: 1300-1303.
14. [14] Buchkovich K, Duffy LA, Harlow Ed. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58: 1097-1105.
15. [15] DeCaprio JA, Ludlow JW, Lynch D et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989; 58: 1085-1095.
16. [16] Ludlow JW, Shon J, Pipas JM et al. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 1990; 60: 387-396.
17. [17] DeCaprio JA, Furukawa Y, Ajchenbaum F et al. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc Natl Acad Sci USA 1992; 89: 1795-1798.
18. [18] Mittnacht S, Lees JA, Desai D et al. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J 1994; 13: 118-127.
19. [19] Dulic V, Lees E, Reed SI. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 1992; 257: 1958-1961.
20. [20] Akiyama T, Ohuchi T, Sumida S et al. Phosphorylation of the retinoblastoma protein by cdk2. Proc Natl Acad Sci USA 1992; 89: 7900-7904.
21. [21] Ewen ME, Sluss HK, Whitehouse LL et al. TGF-β inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 1993; 74: 1009-1020.
22. [22] Zhang KR, Kumar, R. Interferon-α inhibits cyclin E-and D1-dependent cdk2 kinase activity associated with Rb protein and E2F in Daudi cells. Biochem Biophys Res Commun 1994; 200: 522-528.
23. [23] Okamoto Y, Kikuchi E, Matsumoto M et al. Dibutyryl cyclic AMP enhances the down-regulation of RB protein during G1 phase in the proliferating primary rat hepatocytes, but inhibits their entries into S phase and RB's phosphorylation. Biochem Biophys Res Commun 1993; 195: 84-89.
24. [24] Kara E, Tsurui H, Shinozaki A et al. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem Biophys Res Commun 1991; 179: 528-534.
25. [25] Xu H-J, Hu S-X, Hashimoto T et al. The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells. Oncogene 1989; 4: 807-812.
26. [26] Macnab GM, Alexander JJ, Lecatsas G et al. Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer 1976; 34: 509-515.
27. [27] Goodrich DW, Chen Y, Scully P et al. Expression of the retinoblastoma gene product in bladder carcinoma cells associates with a low frequency of tumor formation. Cancer Res 1992; 52: 1968-1973.
28. [28] Christoffersen J, Smeland EB, Stokke T et al. Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells. Cancer Res 1994; 54: 2245-2250.
29. [29] Mohan S, Strong DD, Hilliker S et al. Dibutyryl cyclic adenosine monophosphate differentially regulates cell proliferation in low and high alkaline phosphatase SaOS-2 human osteosarcoma cells: evidence for mediation by the insulin-like growth factor-II system. J Cell Physiol 1993; 156: 462-468.
30. [30] Huang H-JS, Yee J-K, Shew J-Y et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 1988; 242: 1563-1566.
31. [31] Sumegi J, Uzvolgyi E, Klein G. Expression of the RB gene under the control of MuLV-LTR suppresses tumorigenicity of WERI-Rb-27 retinoblastoma cells in immunodefective mice. Cell Growth Differ 1990; 1: 247-250.
32. [32] Takahashi R, Hashimoto T, Xu H-J et al. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sci USA 1991; 88: 5257-5261.